OliX Pharmaceuticals226950
OliX Pharmaceuticals (226950) Amended Material Information, 2026-11-10
Filing date ·
OliX Pharmaceuticals filed a correction to disclose that the New Zealand Phase 2a clinical trial application, which had been rejected on October 12, 2026 for O…
Sign in to read this filing in detail
Continue to the filing details and any available analysis after signing in.
Filing lists and official source links are available without signing in.